The invention provides methods for the treatment of coronary heart disease, peripheral vascular disease, stroke, and ischemia featuring agents that interfere with the expression or activity of Cthrc1. The invention also provides the use of Cthrc1 peptide as a therapeutic agent for the treatment of acute or chronic cardiac deficiencies. The invention further provides detection and monitoring of Cthrc1 peptide in blood or serum to assess or monitor cardiac function.
Maine Medical Center, MaineHealth Institute for Research
Lindner, Volkhard; Pinz, Ilka; and Stohn, Julia Patrizia, "Kit for Detecting CTHRC1 in a Sample" (2013). MaineHealth Patents. 5.
Maine Medical Center